Artwork for podcast The Poison Lab
A Prescription for Heartache (& Seizures) (Bupropion)
Episode 1915th February 2023 • The Poison Lab • Clinical Toxicology LLC
00:00:00 01:30:40

Share Episode

Shownotes

What Do Bath Salts, Face-Eating Zombies, and Antidepressants Have in Common?

In this episode of The Poison Lab, Ryan is joined by Dr. Filip, Dr. Olives, and Dr. Reyes to discuss a unique and heartbreaking poisoning scenario involving an antidepressant now recognized as the #1 cause of major life-threatening effects in antidepressant overdoses in the U.S. Check out the mini-episodes for more details!

Key Highlights

This Antidepressant:

  • #1 Cause of Major (Life-Threatening) Effects in overdoses reported to U.S. Poison Centers.
  • Difficult to manage due to:
  • Delayed seizures.
  • Unique cardiogenic shock in overdose.
  • Wide complex arrhythmia refractory to sodium bicarbonate.
  • Potential interference with brain death testing.

Mechanism of Toxicity

  • Increases dopamine and norepinephrine.
  • Blocks gap junctions in cardiac myocytes:
  • Rohr 2004: Gap junction blockade causes a wide QRS.
  • Vink 2004: Connexin 43 is critical for cardiac signal transmission.
  • Callier 2012: Similar effects on cardiac action potential as other gap junction blockers.
  • Burnham 2014: Bupropion's IC50 for connexin 43 is >50 µM, higher than fluoxetine and lamotrigine.
  • Shaikh Quereshi 2014: Bupropion interferes with connexin 43 production/localization in chicken cardiac myocytes at >50 µM.

Clinical Effects

Sympathetic Toxidrome

  • Seizures: Delayed, typically occurring 8–24 hours post-ingestion.
  • Tachycardia: May precede seizures but could be masked by co-ingestions.

Takeaway (TL;DR):

  • Patients often present with neurologic symptoms and tachycardia before seizures.
  • Do not discharge patients without consulting a toxicologist or poison center regarding observation time.
  • Avoid dismissing tachycardia and anxiety as situational in bupropion overdose cases.

Key Literature Insights

  • Shepherd 2004: Seizures primarily associated with sustained-release products; often preceded by neuropsychiatric symptoms.
  • Starr 2009:
  • XL products linked to seizures.
  • Tachycardia, tremor, and agitation are predictors.
  • Seizures occurred as late as 24 hours; 25% occurred after 8 hours.
  • Offerman 2020:
  • Tachycardia >120 bpm predicts seizures.
  • Late seizures occurred only in symptomatic patients.
  • Prehospital seizure correlated with cardiac arrest.
  • Rianprakaisang 2021:
  • QTc and HR >140 bpm predict seizures.
  • ToxIC review confirmed tachycardia as a risk factor.

Treatment Overview

Decontamination

  • Whole bowel irrigation or activated charcoal may be needed for large ingestions.

Supportive Care

  • Airway Management: Intubate if compromised.
  • Benzodiazepines for agitation or seizures.
  • Use GABA-ergic AEDs for status epilepticus.

Cardiogenic Shock

  • Sodium bicarbonate for wide QRS (though may be refractory).
  • Inodilators/Vasopressors for shock.
  • ECMO for refractory shock or arrhythmias.

Observation Times

  • Late seizures can occur up to 24 hours post-ingestion.
  • Discuss observation times with a toxicologist.

Additional Considerations

  • Severe toxicity can mimic brain death—send for analytical confirmation if possible.
  • Limited enhanced elimination options due to high protein binding.
  • Consider IV lipid emulsion if the patient is peri-arrest.

Don't Fall into Traps:

  • All ingestions are unique. Collaborate with a toxicologist to guide management and avoid pitfalls.

Rohr 2004: "Role of gap junctions in the propagation of the cardiac action potential"

Vink 2004: "Connexin 43 is the most important protein for connexon formation and cardiac signal transmission"

Callier 2012: "QRS widening and QT prolongation under bupropion: a unique cardiac electrophysiological profile"

Shaikh Quereshi 2014: "Bupropion interferes with connexin43 production and localization in chicken cardiac myocytes at concentrations >50 µM"

Shepherd 2004: "Seizures after overdose of sustained-release bupropion"

Starr 2009: "Seizures in extended-release bupropion overdoses"

Offerman 2020: "Predictors of seizures and death in bupropion overdoses: a 10-year retrospective study"

Rianprakaisang 2021: "Risk factors for seizures in bupropion overdose: a ToxIC database study"

Support the show

Reach the show

  • Email: Toxtalk1@gmail.com

More Show Resources

Chapters

Video

More from YouTube